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Abstract 
There are a lot of risks in cancer treatment by invasive surgery, such as bleeding, 
wound infection, and long recovery time, etc. Therefore, there is great need for 
minimally- or non-invasive treatment. High intensity focused ultrasound (HIFU) is a 
rapidly growing and truly non-invasive technology. It has been widely used in therapeutic 
applications, such as rapid tissue heating and tissue ablation. With proper imaging 
guidance, HIFU treatment can be performed totally noninvasively. Currently, ultrasound 
imaging-guided HIFU has been extensively studied. However, ultrasound imaging 
guidance is less precise because of the relatively low imaging contrast, sensitivity, and 
specificity for noninvasive detection. In this study, we employed photoacoustic imaging 
(PAI) technique, which has been developed a novel promising imaging technique for 
early cancer detection, to guide HIFU treatment. The goal of this study is to investigate 
the feasibility of PAI to guide, monitor in real time and enhance the HIFU therapy.  
In this dissertation, as the first step, the integrated PAI and HIFU system had been 
shown to have the feasibility to guide HIFU both ex vivo and in vivo. Then, the system 
was improved and developed to a real-time PAI-guided HIFU system. It is demonstrated 
that the sensitivity of PA detection for HIFU lesion is very high and the saturation of PA 
signals can be used as the indicator for tissue coagulation. During the temperature 
measurement using this system, laser-enhanced HIFU heating was found. Thus, we 
further investigated the laser enhanced technique in both HIFU heating and pulsed HIFU 
thrombolysis. In the HIFU therapy, laser light was employed to illuminate the sample 
concurrently with HIFU radiation. The resulting cavitation was detected with a passive 
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cavitation detector. We demonstrated that concurrent light illumination during HIFU has 
the potential to significantly enhance HIFU by reducing cavitation threshold.  
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Chapter 1 Introduction 
1.1 Background and motivation 
High intensity focused ultrasound (HIFU) has been served as a truly non-invasive 
tool to treat solid tumors[1-9]. During HIFU, high intensity ultrasound is delivered and 
deposits a certain amount of energy to a target. The induced rapid local temperature rise, 
which is called hyperthermia or thermal ablation, leads to the irreversible tissue 
coagulation and cell death. Since HIFU technique was first introduced by Lynn et al.[10] 
in 1942, it has been performed in a growing number of clinical studies on several benign 
and malignant tumors (prostate, breast, uterine, liver, kidney, pancreas, bone, and 
brain)[9, 11-22].  
In the last decade, HIFU have made remarkable achievements in the clinical 
studies with the advent of modern imaging modalities such as ultrasound (US) imaging 
and magnetic resonance imaging (MRI), which can provide accurate therapy guidance. 
Currently, more than 90% of HIFU is performed with ultrasound guidance. 
Although ultrasound imaging is inexpensive and can be performed in real time, it has 
relatively low imaging contrast, sensitivity, and specificity for noninvasive detection[23-
25], which cause loss of guidance accuracy.  In addition, temperature rise during HIFU 
cannot yet be accurately measured with ultrasound, although efforts have been made[26-
30]. Magnetic resonance imaging (MRI) is a more viable imaging technique to guide 
HIFU therapy because it can produce temperature images[31-36]. However, MRI makes 
the treatment expensive and slow. In addition, the patient must remain still in a magnet 
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bore, which may be a problem for claustrophobic patients. In some MRI modes (such as 
head and neck imaging), special RF coils are used to fit closely to the patient’s anatomy, 
and these coils will interfere with HIFU transducer placement. 
Photoacoustic imaging, also called optoacoustic imaging or thermoacoustic 
imaging, has been developed as a novel promising imaging technique for early cancer 
detection[37-44]. It is a hybrid technique that can image the distribution of optical 
absorption deep inside the tissue based on the photoacoustic effect.  When short-pulsed 
laser beams irradiate on the biological tissues, the ultrasonic waves are generated due to 
pressure rise through transient thermoelastic expansion. The ultrasonic waves, referred as 
photoacoustic waves, can be detected by an ultrasonic transducer and then converted to 
electrical signal that can be collected by PC to analyze or form PA images. PAI 
overcomes the limitations of ultrasound imaging modalities and combines optical contrast 
with ultrasonic resolution. PAI has demonstrated imaging depth more than 5 cm[45] with 
the imaging resolution (from 2 µm to 500 µm) scalable to the imaging depth[42, 46]. 
Additionally, PAI has the advantages of being inexpensive and portable. It is 
demonstrated that PAI has the capability to provide guidance for HIFU treatment on solid 
tumors and monitor thermal lesions generated by HIFU or other means[47-50]. 
While HIFU therapy technique with proper imaging modalities is developing 
rapidly, its application is also expanding, e.g. large tumor treatment. It requires larger 
amount of energy deposited in the tumor region, which can be fulfilled by enhancing the 
local ultrasound absorption and ultrasound intensity. Increasing the HIFU intensity is one 
of the simple solutions. However, high power output will induce serve skin burns and 
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also present a great challenge for the design of HIFU system, including the design of 
transducer and the electronic circuits. An alternative way to avoid very high ultrasound 
intensity in large tumor treatment is to increase the local ultrasound absorption so that 
more ultrasound energy can be deposited in the local region at a relatively low HIFU 
intensity level. As a result, enhanced HIFU heating would be achieved at a relatively low 
HIFU intensity level, and side effects such as skin burns would be avoided. To enhance 
HIFU heating, acoustic cavitation has been investigated[51, 52] to have the capacity to 
increase the local ultrasound absorption and thus enhance heating. 
The use of pulsed HIFU to potentiate thrombolysis is another important 
application of HIFU. Catheter-based ultrasound has been extensively studied as an 
efficient method to treat deep venous thrombosis (DVT) clinically[53-59]. During the 
treatment, the catheter is placed inside the blood clot and dissolves the clot through 
oscillating wires at high frequency and high intensity. However, catheter-based 
ultrasound is an invasive way to treat thrombus. The non-invasive methods are necessary 
to avoid bleeding, wound infection, and long recovery time. Therefore, HIFU technique 
has the potential for thrombolysis treatment. When using HIFU to dissolve the blood clot, 
the clot disruption are mainly due to cavitation effect[54, 57, 60-62]. However, using 
pulsed HIFU treatment alone are limited and have a relatively low thrombolysis 
efficiency[63, 64].  
As we mentioned, in HIFU applications, acoustic cavitation plays a vital role in 
both HIFU ablation and pulsed HIFU thrombolysis. When cavitation occurs, collapse 
(stable cavitation) and pulsate violently (inertial cavitation) can damage nearby structures 
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without heating complex overlying layers. However, cavitation thresholds are widely 
varying in tissues and cavitation requires high intensities to initiate. Either 
microbubbles[65-67] or nanoparticle have been studied as a method of delivering nuclei 
into the target region[52]. The addition of intravenously injected microbubbles can 
enhance the effects of ultrasound and lower the energy requirement for producing heating 
effect through decreasing the cavitation threshold.[57, 62, 68, 69] In addition, 
microbubbles and thrombolytic drug can be combined together with HIFU therapy for 
targeted drug delivery, drug transport acceleration[70-77] and eventually enhancing 
HIFU. However, the use of microbubbles and nanoparticle, however, requires the 
systematic injection of foreign particles into the blood stream, and would have a lot 
concerns regarding the toxicity, efficiency, etc[78]. 
1.2 The goal of this research 
In this study, we will first demonstrate that the integrated PAI and HIFU system 
can be used to provide excellent guidance for HIFU treatment in both ex vivo and in vivo 
experiments. Secondly, the integrated system will be modified to monitor HIFU 
treatment in real time. Finally, we will develop and evaluate a new system based on the 
integrated system for laser-enhanced particle-free HIFU heating. During the experiment, 
the laser light will be employed to treat the target area concurrently with HIFU treatment 
to help induce cavitation, which is the key factor for both HIFU heating and thrombolysis 
treatment. The finding, for the first time, will potentially allow us to enhance HIFU 
therapy at a relatively low HIFU intensity level without introducing foreign particles in to 
the targeted tissue region.  
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Chapter 2 The integration of photoacoustic imaging and high intensity 
focused ultrasound 
2.1 Introduction 
High intensity focused ultrasound (HIFU) has been used as an effective non-
invasive method to treat solid tumors deep in the body.  During a HIFU treatment, the 
high intensity ultrasound is delivered to the focal region of the HIFU transducer, and 
subsequently absorbed by the soft tissue in the focal region. The absorption of HIFU 
energy induces a rapid temperature rise, which results in tissue coagulation, and finally 
leads to the irreversible tumor cell death and severe damage to tumor blood vessels in the 
treated region.
 
[8, 79]  The soft tissue outside the focal region will be undamaged because 
the ultrasound intensity is relative low in those regions. 
To improve the effectiveness of HIFU treatment, we need to locate and monitor 
the treated tissue so that the guidance and feedback on the treatment can be provided.[80]  
Current imaging modalities such as magnetic resonance imaging (MRI) and ultrasound 
imaging have been used to visualize the treatment process and monitor the immediate 
thermal effects.[9, 22, 32, 81, 82]  However, MRI makes the treatment cumbersome and 
expensive. Although ultrasound imaging is inexpensive and can potentially perform with 
the same HIFU transducer in real time, it has relatively low imaging contrast, sensitivity, 
and specificity for noninvasive detection. 
Photoacoustic imaging (PAI), also called optoacoustic imaging or thermal 
acoustic imaging, has been developed as a novel promising imaging technique for early 
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cancer detection.[37, 39-41, 43, 83]  PAI is based on the generation of photoacoustic 
waves by safely depositing short-pulsed optical energy into tissue.  Each laser pulse 
causes a rapid temperature rise on the order of 10 millidegrees.  The ultrasonic waves 
generated due to thermoelastic expansion can be detected with either a single-element 
ultrasonic transducer or an array of ultrasonic transducers and then used to reconstruct an 
image.[83]  PAI technology is designed to overcome the poor spatial resolution of purely 
optical imaging yet to retain the high optical contrast in the deep region beyond the depth 
limit, which is ~1 mm,  for high-resolution optical imaging, and demonstrated the 
capability of providing images with optical contrast and ultrasound resolution in regions 
up to 5 cm deep in soft tissue.[45]  
PAI has demonstrated to be capable of monitoring thermal lesions generated by 
HIFU or other means.[49, 50]  A study for PAI guidance of HIFU has also been proposed 
with the application of time-reversal technique.[84]  Currently, PAI and HIFU are 
performed by two separate systems.  When PAI and HIFU are performed separately by 
two systems, a tissue imaging window for PAI, which utilize both light and ultrasound, 
and a therapeutic window for HIFU to deliver ultrasound energy will be required.  In 
clinic practice, two tissue windows are sometimes difficult to be identified.  In addition, 
when two separate systems are used, the location of the two systems needs to be known 
precisely so that the treatment will be performed on the lesion, which is identified on the 
image.  To align the treatment area with the imaging area could be a challenge and may 
result in the ablation of normal tissue.   
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One way to improve PAI-guided HIFU is to use an integrated system for PAI and 
HIFU.  The combination of PAI and HIFU is technically possible.  In PAI technology, 
both laser and ultrasound energy are involved in the imaging process.  The ultrasonic 
transducer’s sole purpose within the modality is to act as a receiver of the acoustic signals. 
If the ultrasonic transducer is used as a transmitter to deliver high ultrasound energy to 
soft tissue, the PAI system potentially has therapeutic applications as a HIFU system.    
HIFU can treat soft tissues up to 10 cm, whereas the deep reflection-mode PAI, 
when a 5-MHz ultrasonic transducer is used, can provide penetration depth up to ~3.8 cm 
without using any contrast agents.[85]  With the aid of PAI contrast agents, the deep 
reflection-mode PAI should be able to image even deeper.  Therefore, a reflection-mode 
PAI-guided HIFU may be used to treat breast tumor, prostate tumor, and tumors in the 
lymphatic system, etc..   
In this paper, we investigated the feasibility of using an integrated PAI and HIFU 
system to non-invasively detect the location of the target tissue sample and then plan and 
perform the HIFU ablation on the target tissue sample. The biggest advantage of a 
combined reflection-mode PAI and HIFU with one transducer lies on the fact that only 
one tissue imaging/therapy window is required with this technique, and therefore, it will 
be much friendly to be used in future clinic practice.  Furthermore, with the combined 
system, the treatment can be performed precisely on the area identified through the 
obtained image, and therefore, the treatment location can be very precise.  This advantage 
may be of more interest when treating small lesions, which may be identified in early 
cancer detections.   
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In the combined PAI/HIFU system, we utilize a reflection-mode PAI (also called 
PAM)[85, 86] with a standard 5-MHz HIFU transducer as our photoacoustic signal 
detector.  The HIFU transducer also delivers high intensity ultrasound energy to soft 
tissue during tissue ablations. Our results show that the combined PAI/HIFU is capable of 
performing imaging and therapy. 
2.2 Materials and Methods 
 
Figure 2.1 Schematic of the integrated PAI and HIFU system 
 
Figure 2.1 shows the schematic of the integrated PAI and HIFU system.  During 
PAI mode, a tunable OPO laser (Surelite OPO PLUS; Continuum), pumped by a Q-
switched Nd:YAG laser (Surelite III; Continuum) is used to generate laser light.  The 
system operates at 680 nm wavelength with a 10 Hz pulse repetition rate for excitation of 
the tissue.  The produced laser light is directed to a conical lens via a group of prisms, 
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which enable higher optical energy delivery[85] than the optical fibers-based PAI 
systems.[86]  The laser passing through the conical lens forms a ring-shaped illumination.  
The ring-shaped light is transmitted to an optical condenser and refocused inside the 
tissue sample.  At the tissue surface, the ring has a diameter of ~5 mm, which has the 
advantage of reducing the generation of surface photoacoustic signals, and allowing for 
the improvement in the detection of deep photoacoustic signals.[85, 86]  The 
subsequently generated photoacoustic signals are detected by a 5-MHz focused ultrasonic 
transducer (SU-108-013, Sonic Concepts), which has a focal length of 35 mm and 
diameter of 33 mm.  The transducer delivers the recorded acoustic signal to a pre-
amplifier (5072PR, Olympus-NDT).  After signal amplification, the detected 
photoacoustic signals are collected by a PC through a digital oscilloscope (Tektronix 
DPO 3034).  The transducer is mounted in the middle of the condenser lens and driven by 
a XYZ-linear translation stage for raster scanning on the tissue sample.  Two prisms are 
used to enable the beam-folding for the 2D scan.  Prism Y can only move on the Y 
direction, whereas prism XY can move on both X and Y direction.  This design for PAI 
has been presented by Song et al.[85] for deep PAI, and proved to generate good-
resolution photoacoustic images in deep regions inside soft tissue.   
During HIFU mode, the 5-MHz focused ultrasonic transducer was used as a 
transmitter. At each scanning position, a continuous ultrasonic wave, which was 
generated by a function generator (HP33250A; Agilent Technologies) and amplified by a 
50 dB RF amplifier (350L; ENI Technology, Inc), was sent to the transducer. The 
transducer, which was driven by PC-controlled motors, induced the HIFU field step by 
step in the tissue sample. 
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In order to quantify the actual resolution of our PAI system with the HIFU 
transducer as a receiver, a well-controlled sample (human hair, ~50 µm in diameter) in 
water was imaged.  Figure 2.2 shows the cross-section of the human hair on a B-mode 
scan image.  We can achieve a lateral resolution of ~270 µm and an axial resolution of 
~200 µm.   
 
Figure 2.2 The cross-section of a human hair in water. 
 
To test the ability of the system in the detection of optical contrast change before 
and after HIFU, we performed in vitro test in a chicken liver.  A slice (2 mm thick) of 
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chicken liver was imaged first, and then HIFU was used to sonicated a portion of the liver.  
After HIFU sonication, PAI was used to image the liver slice again. 
To further simulate the tumor detections by PAI and localized ablation by HIFU, 
we embedded a thin slice of swine liver tissue (2-mm thick) between two fresh chicken 
breast tissues slabs.  The thicknesses of the two chicken breast slabs were different.  The 
upper slab was ~1-mm thick, while the lower slab was approximately 10-mm thick and 
much larger than the upper slab in order to reduce the interference from signals generated 
at the bottom of the sample.  The samples were immersed in water, and air bubbles were 
carefully removed before PAI.  Since the optical absorption in the swine liver tissue is 
much higher than that in the chicken breast tissue, good image contrast should be 
achieved between them.  During the experiments, PAI was first used to detect the 
location of the swine liver, and then, HIFU ablation was performed based on the exact 
position of the swine liver sample identified on the photoacoustic image.  After HIFU 
ablation, PAI was performed again to detect the change on the generated photoacoustic 
signals.  
For the photoacoustic image formation, we take maximum-amplitude-projected 
(MAP) image. On a MAP image, the maximum value of the photoacoustic signal 
detected at each scan position is plotted. 
2.3 Results 
Figure 2.3 (a) shows the photoacoustic image of the chicken liver after a portion 
of the liver went through the HIFU ablation, whereas figure 3 (b) shows the photograph 
of the chicken liver.  Compared with other untreated region, the HIFU treated region 
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shows a great enhancement in the amplitude of photoacoustic signals.  On the image, the 
averaged contrast ratio between the treated and untreated region is about 3.6, with a 
standard deviation of 1.8.  The increase in the amplitude of photoacoustic signals after 
HIFU treatment is consistent with previous results[49, 50].  The increase in the amplitude 
of photoacoustic signals after HIFU can be caused by a combination of several factors.  
Notably, the Grüneisen parameter is affected by tissue coagulation.[87]  The intensity at 
the focal region was estimated to be 10
4 
W/cm
2
 during the HIFU ablation, and the 
treatment duration was 1 s. 
Photoacoustic images of the swine liver tissue in chicken breast tissues before and 
after HIFU are presented in Figure 2.4.  Figure 2.4(a) was taken before HIFU ablation on 
the swine liver sample and it shows the location of liver tissue and shape, which acted as 
the guidance for the subsequent HIFU ablation.  For HIFU ablation, we chose the 
scanning area of 5.4 mm×7 mm which accurately cover the entire area of the liver and 
avoid burning the surrounding tissue.  The step size of the scanning on the sample was 
0.2 mm.  At each scanning position, the ultrasonic wave was focused into the sample for 
4 s, with a focal intensity of 10
3 
W/cm
2
.  Compared with Figure 2.4(a), Figure 2.4(b), 
which is the photoacoustic image after HIFU ablation, reveals the swine liver tissue with 
approximately the same size and slight increase at PAI contrast, which is shown by the 
increased photoacoustic signal amplitudes in the MAP image.  Figure 2.4(c) and (d) 
shows the photograph of the liver tissue before and after HIFU ablation. 
To quantify the change in the photoacoustic image after HIFU, we calculated 
averaged enhancement in the amplitude of photoacoustic signals before and after HIFU in 
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the HIFU treated region.  The average enhancement is ~6 % with a standard deviation of 
4%.  The enhancement in photoacoustic signals is small because the ultrasound intensity 
at the focal region was only 10
3
 W/cm
2
, and the treatment duration was 4 s for current 
HIFU ablation.  We anticipate that a higher enhancement in photoacoustic signal should 
be achieved if a higher ultrasound intensity level at the focal region is used during HIFU 
ablation, as shown in Figure 2.3. 
 
Figure 2.3 (a) Photoacoustic image of a chicken liver after HIFU ablation.  The 
ultrasound intensity at the focal zone is 10
4
 W/cm2, the ablation duration is 1 s at each 
scanning position.  (b) Photograph of  the chicken liver after HIFU ablation. The HIFU 
targeted area is outlined on (a).  
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The results in Figure 2.4 demonstrate that the combined PAI/HIFU system with 
one transducer is capable of perform PAI-guided HIFU ablation.  PAI can be performed 
to identify the location of the targeted region, and HIFU can then be performed to ablate 
the targeted tissue.  At the end, PAI can be performed again to confirm the HIFU ablation. 
 
Figure 2.4 Photoacoustic images of a piece of swine liver embedded in the chicken breast 
(a) before the HIFU ablation and (b) after HIFU ablation. The ultrasound intensity at the 
focal zone is 10
3
 W/cm2, and the ablation duration is 4 s. (c) and (d) are photographs of 
the swine liver before and after HIFU ablation, respectively. 
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2.4 Discussion and Conclusions 
An integrated PAI and HIFU system was presented in current research.  We 
demonstrate that with one system, PAI can be used as a guidance and evaluation tool for 
HIFU ablation.  A combined reflection-mode PAI and HIFU with one transducer will 
only need one tissue window for both imaging and therapy, and therefore, it will be much 
friendly to be used in future clinic practice.  With the combined system, precise 
alignments between treated areas and planned treatment areas, which is indentified on the 
image, during the therapeutic phase can be assured relatively easy, and therefore, the 
ablation can be performed precisely on the area identified through the obtained image.  
We have used a 5-MHz HIFU transducer for PAI in this system.  Usually, a 
focused, broadband (>70% bandwidth) transducer is preferred for the reflection-mode 
PAI (or PAM).  A broadband transducer will provide good axial resolution, whereas the 
lateral resolution is determined by the focusing effect of the transducer.  The drawback of 
using a broadband transducer is that a broadband transducer usually has a relative low 
sensitivity.  For HIFU application, we usually use narrowband transducer to achieve best 
energy delivery.  When a narrowband transducer is used for PAI, the axial resolution will 
become worse than that of using a broadband transducer, whereas lateral resolution 
should be the same because it depends on the focusing effect.  However, one advantage 
of using a narrowband transducer is that a narrowband transducer usually has higher 
sensitivity than a broadband transducer.  In summary, when we use a HIFU transducer for 
PAI, we will sacrifice the axial resolution, but gain high sensitivity.  For deep reflection-
mode PAI, a high sensitivity may be of more interest.  When we use our HIFU transducer, 
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which has a factional bandwidth of ~ 50%, as a PAI receiver, a reasonable axial 
resolution is obtained (Figure 2.2).  Therefore, we believe the proposed technique is 
feasible and promising.   
Additionally, the current system used a single-element transducer for PAI and 
HIFU, therefore, mechanical scans are required to conduct the imaging process and HIFU 
ablation.  A phased array can be used in the future to reduce the time required for 
imaging and therapy.  We envision that PAI technique may potentially be combined with 
HIFU ablation for image-guided therapy. 
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Chapter 3 In-vivo imaging and treatment of solid tumor using 
integrated photoacoustic imaging and high intensity focused ultrasound 
system 
3.1 Introduction 
High-intensity focused ultrasound (HIFU) has been used in clinics as a non-
invasive technique for the treatment of solid tumors.[8]  During HIFU treatment, a HIFU 
transducer is used to ablate soft tissue in the focal zone of the HIFU transducer through 
thermal and mechanical effects produced by HIFU beams.  By mechanically scanning the 
transducer, the whole tumor area can be ablated with little or no damage on the 
surrounding tissue.  The main advantage of this technology is its non-invasive nature, and 
therefore, HIFU has been used in clinical treatment of several types of cancers such as 
breast cancer and prostate cancer.[1, 11, 79, 88-90] 
To accurately treat a solid tumor, imaging techniques for locating the solid tumor 
and monitoring HIFU treatment are always performed before and after HIFU ablation.  
Photoacoustic imaging (PAI) technique is a novel promising imaging modality, which 
can be used to guide HIFU ablation.  PAI is a hybrid technique that can image the 
distribution of optical absorption deep inside the tissue based on photoacoustic effect.  
When short-pulsed laser beams irradiate on biological tissues, ultrasonic waves are 
generated due to pressure rise from transient thermoelastic expansions.  The ultrasonic 
waves, referred as photoacoustic waves, are detected by an ultrasonic transducer and then 
converted to electrical signal that can be collected by a PC to analyze or form 
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photoacoustic images.  Although several groups showed that magnetic resonance imaging 
(MRI),[32, 91, 92] thermoacoustic tomography (TAT),[93] ultrasound imaging[25, 94] 
have the capabilities of monitoring the thermal lesion generated by HIFU in the targeted 
region, PAI has certain advantages and has already been used to visualize HIFU 
treatment.[49, 50]  One of the advantages of PAI over other imaging modalities is its 
potential for versatile and minimally invasive molecular imaging for visualization of 
solid tumors with the assistance of contrast agents such as nanoparticles.  Recently, 
photoacoustic microscopy (PAM) had been used to non-invasively image extravasation 
and accumulation of gold nanorods within a CT26 murine colon carcinoma tumor in 
vivo.[95]  Gold nanorods have also been used to provide high contrast between targeted 
and nontargeted tissue for photoacoustic molecular imaging in vitro and in vivo.[96, 97]   
We have developed an integrated PAI/HIFU system[98] previously.  In this study, 
we will show the feasibility of the combination of photoacoustic imaging and HIFU 
treatment with the integrated PAI and HIFU system in vivo.  PAI will be enhanced by 
gold nanorods through extravasation in vivo.  HIFU ablation of the tumor will then be 
performed under the guidance of PAI.   
3.2 Materials and methods 
3.2.1 Integrated PAI/HIFU system 
Figure 3.1 shows the schematic of the integrated PAI and HIFU system.[98]  
When the system was operating in PAI mode, pulsed laser light with a 10-Hz repetition 
rate was produced by a tunable OPO laser (Surelite OPO PLUS; Continuum, Santa Clara, 
CA) that was pumped by a Q-switched Nd:YAG laser (Surelite III; Continuum, Santa 
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Clara, CA).  The pulse width of the laser was 6 ns and the tunable wavelength range for 
the OPO laser was from 680 to 980 nm.  The generated laser pulses were directed by a 
couple of prisms and then formed a ring-shaped illumination by a conical lens.  A 
condenser lens was used to make the laser light confocal with a 5-MHz focused 
ultrasonic transducer (SU-108-013; Sonic Concepts, Bothell, WA) which was mounted in 
the middle of the condenser lens.  The conical and condenser lenses were driven by a 3D 
translation stage to enable the transducer to mechanically scan the targeted region.  Two 
prisms were used to enable the optical beam-folding for a 2D mechanical scanning.  
Prism Y could only move on the Y direction, whereas prism XY could move on both X 
and Y direction.  This design has been presented by Song et al. [46] for deep PAI, and 
proved to generate good-resolution photoacoustic images in deep regions inside soft 
tissue.  The ultrasonic transducer scanned above the sample continuously with a speed of 
0.5 mm/s and collected data every 0.05 mm along x-axis, while the step size along y-axis 
was 0.1 mm.  It took ~45 min to scan a 10 mm × 10 mm area.  On the tissue surface, the 
laser spot had a diameter of ~5mm and the laser intensity was restricted to 20 mJ/cm
2
, 
which complied with the laser safety limit of American National Standards Institute 
(ANSI).  The 5-MHz transducer had a fractional bandwidth of 60% with 35 mm focal 
length and 33 mm aperture size, respectively.  Although the fractional bandwidth is 
relatively low, it is a necessary tradeoff in an inexpensive integrated imaging and therapy 
transducer.  The transducer was immersed in a water tank which had a window on the 
bottom sealed with polyethylene membrane.  The sample coated with ultrasound gel was 
laid on the other side of the membrane.  The recorded photoacoustic signals by the 
transducer were amplified through a pre- amplifier (5072PR; Olympus-NDT, Waltham, 
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MA) and then collected by a PC through an A/D Scope Card (CS21G8-256MS; Gage, 
Lockport, IL) with a 500-MHz sampling rate.   
 
Figure 3.1 Schematic of the integrated PAI and HIFU system. 
 
When the system was operating in HIFU mode, continuous waves were generated 
by a function generator (HP33250A; Agilent Technologies, Santa Clara, CA) and 
amplified by a 50-dB radio frequency amplifier (350L; ENI Technology, Inc., Rochester, 
NY) before the waves were sent to the ultrasonic transducer.  HIFU lesions were induced 
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at each scanning position before the transducer was stepped 0.2 mm.  The actual 
ultrasound intensity at each position was approximately 3000 W/cm
2
. 
3.2.2 In vitro test for imaging resolution and depth 
 
Figure 3.2 (a) B-scan image of a human hair in water. (b) Signal profile at the vertical 
dashed line position in (a). (c) Signal profile at the horizontal dashed line position in (a). 
 
As the first step, the imaging capability of the system was tested.  A sample 
(human hair, ~50 µm in diameter) in water was imaged to quantify the lateral and axial 
resolutions of the integrated PAI/HIFU system.  The hair was placed in the focal region 
of the focused ultrasound transducer, i.e., 35 mm away from the transducer.  The laser 
wavelength used was 680 nm.  Figure 3.2(a) shows the cross-section image of the hair, 
whereas Figure 3.2(b) and (c) show the corresponding photoacoustic signals at the 
locations that are marked on the image.  From Figure 3.2 (b), the lateral resolution is 
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estimated to be ~270 µm, and from Figure 3.2 (c), the axial resolution is estimated to be 
~220 µm.  Note that the resolutions are all estimated in the focal region of the focused 
ultrasound transducer.  As it moves away from the focal region, the lateral resolution will 
deteriorate, as shown by Song et al. [46] 
 
Figure 3.3 Photoacoustic image of a carbon rod in chicken breast tissue. The surface of 
the breast tissue is located at 3-mm on z-axis. 
 
To test the imaging depth in soft tissue, we used the integrated PAI/HIFU system 
to image a buried 500-µm diameter carbon rod in chicken breast tissue.  This image was 
obtained by simply scanning the ultrasonic transducer across the sample, and no signal 
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averaging was used. The laser wavelength of 800 nm was used for this test to achieve 
deep penetration.  Figure 3.3 shows the carbon rod is clear imaged at a depth of ~40 mm 
with a signal-to-noise ratio (SNR) of 26 dB.   
3.2.3 In vitro test for gold nanorods 
 
Figure 3.4 Normalized PA signals from saline solution and gold nanorod solution as a 
function of wavelength. Line with circles: pure 0.9% saline solution; line with dots: gold 
nanorod solution.  Error bar represents plus and minus one standard deviation. 
 
During PAI, near-infrared (NIR) light is frequently used to achieve deep imaging 
depth. However, in comparison to using visible light, the contrast of PAI is low when 
NIR light is used.  Gold nanoparticles can be used to improve the image contrast of PAI.  
In this study, we used gold nanorods to enhance the PAI detection of tumor in an in vivo 
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small animal model.  Prior to animal experiments, the peak optical absorption wavelength 
of gold nanorods (30-PM-700-1, Nanopartz, Loveland, CO) was measured using 
integrated PAI/HIFU system.  Nanorods suspended in 0.9% saline solution with a 
concentration of 3×10
11
 nanorods/ml were injected into a clear Polyvinyl chloride (PVC) 
tube (~1 mm inner diameter).  The generated PA signals from nanorods at different laser 
wavelengths were collected and averaged 64 times.  The PA signals from pure saline 
solution were also collected for comparison with the signals from the nanorods.  The 
same laser power was used for all excitation wavelengths, and the wavelength used was 
680 nm. Signals from a photodiode were used to compensate for pulse-to-pulse 
fluctuations in laser energy.  Figure 3.4 shows that strong PA signals are generated from 
the nanorod solution, whereas the PA signals from pure saline solution-filled tube are 
very weak.  Figure 3.4 also shows that these nanorods produce strongest PA signals at the 
wavelength of ~685 nm. 
3.2.4 Animal preparation and experiment procedure 
CT26.WT murine colon carcinoma cells (ATCC, Manassas, VA) were 
administered subcutaneously on the hip of BALB/c mice weighting about 20 g.  7 to 10 
days after the inoculation, tumors were ready to be imaged and treated.  Before the 
experiment, a mouse was anesthetized with a mixture of Ketamine (87 mg/kg body 
weight) and Xylazine (13 mg/kg body weight).  Then hairs at the tumor region were 
shaved.  After shaving, the animal was coated with ultrasonic gel at the tumor area, and 
placed under the membrane of the water tank for imaging and treatment.  During the in 
vivo experiment, the animal was kept under anesthesia by the inhalation of isoflurane gas 
with a dose of 1% in pure oxygen at a 1-L/min flow rate. A pulse oximeter (PulseSense 
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VET; Nonin Medical Inc., Plymouth, MN) was used to monitor the heart beat rate and 
saturation of peripheral oxygen (SpO2) of the animal.  PAI was first performed to get a 
reference image. Then, gold nanorods with a dose of 9×10
9
 nanorods/ g body weight 
were injected intravenously through tail vein.  PAI was performed again 30 minutes after 
the injection of the nanorods.  After PA images were obtained, HIFU treatment on the 
specific tumor area determined by PA images was performed.  HIFU treatment duration 
was 1 s at each scanning position, and the actual ultrasound intensity at each position was 
approximately 3000 W/cm
2
. After HIFU ablation, PAI was performed again. Then the 
animals were returned to their cages, and the recovery process was monitored for the 
following two weeks in order to evaluate whether the tumor was completely ablated by 
HIFU.  The photographs of HIFU treated area were taken every day. 
3.3 Results and Discussion 
Maximum-amplitude-projected (MAP) images obtained from the animal 
experiment are shown in Figure 3.5.  Figure 3.5(a) and (b) are PA images before and after 
injection of nanorods, respectively.  Because of the low optical absorption in NIR region, 
we can only obtain the signals from blood vessels and background tissue with a relatively 
low optical absorption contrast in Figure 3.5(a) without nanorod injection.  The 
significant change from Figure 3.5(a) to Figure 3.5(b) was caused by the accumulation of 
nanorods in the tumor, and it revealed the shape and position of the tumor.  In addition, 
the amplitude of photoacoustic signals from the blood vessel increases, because nanorods 
exist in the circulation system of the mouse.  Based on the tumor information shown in 
the previous images, we planned the HIFU treatment on the tumor area.  Figure 3.5(c) 
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presents the MAP image after the HIFU ablation, the tumor region also shows great 
photoacoustic signal enhancement comparing with Figure 3.5(a).  This enhancement 
might be also caused by the increase of Grüneisen parameter due to tissue 
coagulation.[99]  Some features in Figure 3.5 (a) and (b) are not shown in Figure 3.5(c) 
because of the possible position shift during HIFU ablations. 
 
Figure 3.5 Noninvasive MAP images taken before gold nanorod injection (a), after 
nanorod injection (b), and after HIFU ablation (c).  All PA images are normalized by the 
maximum intensity of all three images, and are shown at the same intensity grayscale. 
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The HIFU lesion was monitored for about 2 weeks after the HIFU treatment.  
Figure 3.6(a), 6(b), 6(c) and 6(d) are the photographs taken prior to, right after, 5 days 
and 16 days after HIFU treatment, respectively.  These photographs show the recovery 
process of the tumor during the two weeks after HIFU ablations, and no tumor growth 
was observed.  The results demonstrate that the tumor was completely ablated by the 
HIFU treatment.  
 
Figure 3.6 Photographs taken prior to (a), right after (b), 5 days after (c) and 16 days (d) 
after HIFU treatment. All photos are at the same length scale. 
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The animal experiment in this study was performed to image and treat 
subcutaneous tumors.  However, the capacity of imaging deep target in the soft tissue was 
also demonstrated in Figure 3.3.  Therefore, this technique will be able to apply for the 
treatment of relatively deep tumors, such as breast tumor and prostate tumor.  In this 
study, the sole purpose of nanoparticle is to improve imaging contrast.  The application of 
nanoparticle-based contrast agents can greatly extend the current technique.  From 
imaging point of view, nanoparticle-based contrast agents help PAI to image deeper 
within tissue with enhanced contrast because nanoparticles are usually designed with 
peak absorption in the NIR region.  In addition, targeting peptides and antibodies can be 
conjugated to the nanoparticle surface for cell specific contrast and molecular imaging, 
which may be used to target specific tumor cells during PAI-guided HIFU.  The 
application of gold nanoparticles can also potentially enhance HIFU by enhancing 
cavitation effect.[100] 
3.4 Conclusion 
In summary, we demonstrated from one case that photoacoustic imaging could act 
as the guidance and evaluation tool for HIFU treatment in in vivo tests.  The application 
of gold nanorods greatly increased the imaging contrast of PAI, and as a results, the solid 
tumor was identified and ablated by HIFU.  The future work may include of using 
actively targeted nanoparticles for photoacoustic molecular imaging and guiding the 
subsequent HIFU treatment. 
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Chapter 4 Real-time monitoring of high-intensity focused ultrasound 
ablations with photoacoustic technique: an in vitro study 
4.1 Introduction 
High intensity focused ultrasound (HIFU) is rapidly growing as an accepted 
clinical therapeutic modality enabling non-invasive tissue ablation[2].  During HIFU 
treatment, focused ultrasound energy is delivered into soft tissue and high acoustic 
intensity is achieved in the focal zone of the ultrasound transducer, whereas acoustic 
intensity is low in regions outside the focal zone. After the high intensity ultrasound is 
absorbed by the soft tissue, local heating is created, and subsequent cell death is induced 
by coagulation necrosis[8, 9, 18, 25, 79, 101-104]. HIFU is a non-invasive therapy 
modality that avoids the insertion of probes into the targeted tissue. The high power 
focused ultrasonic beams employed are generated from sources placed either outside the 
body (for treatment of tumors of the liver, kidney, breast, uterus, pancreas and bone[8]) 
or in the rectum (for treatment of the prostate[18, 19, 21, 102, 103, 105-107]).  Currently, 
thousands of patients are treated with HIFU every year worldwide.  The role of HIFU in 
oncology is likely to continue expanding as devices become more widely available. 
HIFU requires a suitable imaging technique to visualize the target and monitor the 
tumor ablation process[2, 79, 108]. While imaging guidance could provide the 
encouragement for increased clinical use and expand applications of HIFU, the choice of 
imaging platform to employ is still a matter of debate. Currently, the majority of clinical 
HIFU treatments is performed with ultrasound guidance. Although ultrasound imaging is 
inexpensive and can be performed in real time[23-25, 109], it has relatively low imaging 
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contrast, sensitivity, and specificity for noninvasive detection.  In addition, temperature 
rise during HIFU cannot yet be accurately measured with ultrasound, especially when 
cavitation occurs, although efforts have been made[26-30]. In some respects, magnetic 
resonance imaging (MRI) is a more viable imaging technique to guide HIFU therapy 
because it can produce temperature images[8, 22, 80-82]. However, MRI makes the 
treatment expensive. In addition to the high equipment and operating costs, MRI requires 
the patient to be placed inside a magnet. The magnet bore restricts patient access for 
HIFU treatment and complicates positioning of the HIFU applicator. In some MRI modes 
(such as head and neck imaging), special RF coils are used to fit closely to the patient’s 
anatomy, and these coils will interfere with HIFU transducer placement.  
Photoacoustic imaging (PAI), also called optoacoustic imaging or thermoacoustic 
imaging, has been developed as a novel promising imaging technique for early cancer 
detection[37-41, 44].  PAI is based on the generation of photoacoustic waves by safely 
depositing short-pulsed optical energy into tissue, and then detecting these waves with a 
diagnostic imaging transducer, acting as a receiver to uncover local tissue 
abnormalities[42-44].  PAI overcomes the limitations of other existing modalities and 
combines optical contrast with ultrasonic resolution.  PAI has demonstrated imaging 
depth up to 5 cm[45] with the imaging resolution (from 2 µm to 500 µm) scalable to the 
imaging depth[42, 110].  Because PAI is based on optical absorption, it can be 
implemented quickly and inexpensively, with relatively simple instrumentation 
requirements and no ionization. 
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PAI has demonstrated the capability to monitor thermal lesions generated by 
HIFU or other means[47-50, 87, 111]. However, all study up to date was focused on the 
monitoring of temperature with PAI during HIFU.  Although PA signals are sensitive to 
temperature rise, monitoring temperature with PAI during HIFU may not provide 
accurate indication for tissue coagulation.  The generation of PA signals depends on the 
optical properties of the sample.  PA signals will change if the optical properties of the 
sample changes. For example, tissue samples may coagulate at a constant temperature, 
e.g. 50 
o
C, and therefore, the optical properties of tissue sample will change under the 
constant temperature.  As a result, PA signals will change at this constant temperature.  In 
other words, PA signals are related to heating rate, and the signal amplitude is a function 
of temperature and heating duration, which are coupled parameters during the 
coagulation process and cannot be separated.  Therefore, the utilization of PAI to 
monitoring temperature rise during thermal ablation without considering heating duration 
may not be possible.   
In this paper, we propose to use PAI to monitor thermal dose, which is a function 
of heating duration and temperature, and a direct indicator for tissue coagulation, during 
HIFU exposure.  We employed an integrated PAI and HIFU system we developed 
previously[112] to monitor HIFU ablation on beef kidney in real time.  Two ultrasonic 
focused transducers were employed to deliver HIFU energy and receive photoacoustic 
signals. Temperature rise during HIFU ablation was also measured with a thermocouple 
and the thermal dose was calculated.  Therefore, PA signals were related to tissue 
coagulation through thermal dose.  We demonstrated that a relationship between PA 
32 
 
signal amplitude and thermal dose should be developed and used to monitor thermal 
ablation. 
4.2 Materials and methods 
 
Figure 4.1 Diagram of experimental setup.          
 
The experimental setup is shown in Figure 4.1.  A tunable Optical parametric 
oscillator (OPO) laser (Surelite OPO PLUS; Continuum, Santa Clara, CA), pumped by a 
Q-switched Nd:YAG laser (Surelite; Continuum, Santa Clara, CA) with a pulse repetition 
rate of 10 Hz, was employed as the irradiation source.  The generated laser pulses were 
directed by three prisms and then formed a ring-shaped illumination by a conical lens.  A 
condenser lens was used to make the laser light confocal with a 5-MHz HIFU transducer 
(SU-108-013; Sonic Concepts, Bothell, WA) which was mounted in the middle of the 
condenser lens.  A 10-MHz focused ultrasonic transducer (37.5 mm focal length; 65.81% 
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-6-dB fractional bandwidth, Olympus NDT, Waltham, MA)) which acted as a 
photoacoustic detector was aligned to be confocal with the HIFU transducer and laser 
light prior to the measurements.  Both transducers were immersed in a water tank which 
had a window on the bottom sealed with a piece of polyethylene membrane.  Tissue 
sample coated with ultrasound gel was laid on the other side of the membrane.  A 25-µm 
diameter, T type thermocouple was placed 0.5 mm away from the focal point of 
transducers on the sample surface to measure the temperature rise during the HIFU 
ablation as well.  
During the experiment, a function generator (HP33250A; Agilent Technologies, 
Santa Clara, CA) was used to provide the source signals to drive the HIFU transducer. 
The source signals were amplified by a 50-dB radio frequency amplifier (350L; ENI 
Technology, Inc., Rochester, NY) and were then sent to the HIFU transducer. The 
recorded photoacoustic signals from the focal region of the HIFU transducer by the 10-
MHz transducer were amplified through a pre-amplifier (5072PR; Olympus-NDT, 
Waltham, MA) and then collected by a PC through an A/D Scope Card (CS21G8-256MS; 
Gage, Lockport, IL) with a 125-MHz sampling rate.   
Imaging data acquisition and the generation of HIFU waves from the function 
generator were synchronized, and triggered by the laser system. To avoid signal 
interference between HIFU and PAI, HIFU signals were turned off for 10 ms after each 
190 ms sonication.  The 10 ms time window allowed one clear PA signal to be collected 
from the HIFU treated spot while the heating process was not disrupted. The temperature 
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induced by HIFU was monitored at the same time with the T-type thermocouple.  Figure 
4.2 shows the time sequence of imaging data acquisition and HIFU treatment.   
 
Figure 4.2 Time sequence of data acquisition and HIFU waves.  
 
Thermal dose was calculated using the formula suggested by Sapareto and Dewey 
[113].  Thermal dose at 43˚C is given by the relationship: 
TD43 =  R
43−T∆tt=finalt=0                                                    (1) 
where TD43 is the equivalent time at 43°C, R is 0.5 when T is above 43˚C and 
0.25 when T is below 43˚C, T is the temperature during Δt.  A thermal dose of 240 
equivalent minutes at 43 ˚C is widely regarded as the critical value for tissue coagulation.  
4.3 Results and Discussion  
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Figure 4.3 Results from five separated experiments with an intensity of 1000W/cm
2
, 14s 
duration. (a), (b) the averaged PA amplitude and temperature with standard error of the 
mean (SEM), respectively, (c) the relation between the PA amplitude and the calculated 
thermal dose from the averaged temperature, and (d) photographs of beef kidney after 
HIFU treatment. 
 
Figure 4.3 shows the averaged results of five experiments with an HIFU focal 
intensity of 1000 W/cm
2
 and 14-second duration in different beef kidney samples.  In 
Figure 4.3(a) and (b), the averaged PA amplitude and measured temperature with 
standard error of the mean (SEM) are presented, where SEM shows the range for the 
averaged PA amplitude.  In the beginning part of the HIFU ablation, both the PA 
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amplitude and temperature keep increasing.  After about 8 s, the PA amplitude and 
temperature tends to reach a constant value because the targeted area of the sample is 
fully coagulated.  Figure 4.3(c) shows the PA amplitude as a function of calculated 
thermal dose from measured temperatures by the T-type thermocouple.  It shows that the 
relative constant amplitude occurs at TD43 of around 240 minutes at 43 ˚C, which 
indicates the coagulation of tissue.  Additionally, in comparison with the beginning of the 
ablation, PA signal amplitude increased 3 times at the end of HIFU ablation. This result 
implies that PA detection is highly sensitive to detect HIFU ablation.  Figure 4.3(d) 
shows the photograph of the lesion generated under this exposure which was on the 
surface of the renal cortex tissue of beef kidney.   
 
As we have mentioned previously, HIFU ablation process is a dynamic process, 
and the tissue property change, which results in the change in PA amplitude, is a function 
of both temperature and heating duration.  An experiment such as the one shown in 
Figure 4.3 shows the combined effect of both temperature and heating duration.  To 
separate the effect of these two factors on PA signals, we conducted the follow 
experiments. 
To monitor the sole effect of temperature, we used HIFU to ablate the targeted 
sample for 40 s at 1000 W/cm
2
 focal intensity to make sure the targeted tissue is fully 
coagulated, i.e., no more tissue property change even if the high temperature is 
maintained.  Then HIFU was turned off, and both PA signals and temperatures were 
recorded during the cooling stage.  Because the tissue sample was already completely 
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coagulated, the changes in PA signals were purely induced by the changes of temperature 
during this process.  Figure 4.4 shows the recorded PA amplitude as the function of 
temperature. We can observe a linear relation between PA amplitude and temperature. 
This liner relationship is not unexpected because it has been shown by others in vitro 
[114]. 
 
Figure 4.4 PA amplitude as the function of temperature and the linear fit. The coefficient 
of determination R
2
=0.8727. 
 
To monitor the sole effect of heating duration, we placed a piece of beef kidney (3 
mm thick) into a constant 50˚C water bath.  PA signals generated from the surface of the 
beef kidney were monitored continuously. A T-type thermocouple was also placed at the 
tissue surface to monitor the temperature.  Throughout the experiment, the temperature at 
the tissue surface stayed at 50 C  0.2 C.  The recorded PA amplitude is presented in 
Figure 4.5.  From Figure 4.5(a), we observe that PA amplitude increases initially and then 
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after about 3 minutes, PA signals stays at a constant level.  Figure 4.5 (b) shows the 
calculated thermal dose, which shows that PA amplitude stays relative constant beginning 
around 240 TD43 minutes, which indicates the tissue is fully coagulated. 
 
Figure 4.5 (a) PA amplitudes from a beef kidney sample placed in a 50˚C temperature 
water bath; (b) the relation between the PA amplitude and the calculated thermal dose. 
 
Figure 4.5 indicates that PA amplitude changes under a constant temperature over 
an appreciate time.  This result is not unexpected because tissue coagulation occurs at a 
constant temperature, e.g. 50 C, and tissue optical properties change during the 
coagulation.  As a result, PA signals will change.  Therefore, it may not be proper to 
monitor the temperature changes during HIFU ablation by using PA signal amplitude 
because HIFU ablation may not induce instantaneous change in temperature.  If HIFU 
treatment could induce nearly-instantaneously temperature rise, then PA detection would 
be accurate correlated to temperature at the beginning stage of the treatment.  
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4.4 Conclusion 
In summary, there are three findings from this study. The first finding is that PA 
amplitude tends to have a saturation (relative constant) stage after the soft tissue is 
completely coagulated, which is indicated by a thermal dose of 240 or more equivalent 
minutes at 43 ˚C.  Therefore, it is safe to conclude that the saturation of PA amplitude  
indicates the completed tissue coagulation. The second finding is that PA technique may 
not be used to detect temperature rise during thermal ablation because PA signal changes 
under a constant temperature. Combined with our first finding, we believe that it will be 
more appropriate that a relationship between PA signal amplitude and thermal dose 
should be developed and used to monitor thermal coagulation.  The third finding is that 
the change in PA amplitude during HIFU is about 3-fold (Figure 4.3). Therefore, the 
sensitivity of PA detection for HIFU lesion is sufficient high. 
Based on the above findings, we believe that monitoring thermal dose may be a 
more appropriate method in thermal ablation process than monitoring temperature by PAI, 
since the monitoring of temperature changes through the detected PA signals during 
thermal ablation may not be feasible. This conclusion is based on the fact that the 
detected PA signals can change under a constant temperature, and temperature rise may 
not be instantaneous during HIFU treatment.  Based on our current results, the saturation 
of PA signal should be used as the indicator for tissue coagulation.  
 
 
  
40 
 
Chapter 5 Enhanced-heating effect during photoacoustic imaging-
guided high-intensity focused ultrasound 
High-intensity focused ultrasound (HIFU) is a truly non-invasive thermal-ablation 
technique that avoids insertion of probes into targeted tissue. HIFU works through 
rapidly depositing high-intensity ultrasound energy into a small region to induce cell 
death, primarily by hyperthermia, after high-intensity ultrasound is absorbed by soft 
tissue[8, 9, 79, 104]. HIFU has been successfully demonstrated in animal models of 
cancer and in limited clinical studies in the United States[2].  
To perform HIFU treatment non-invasively, an imaging technique is required. 
Photoacoustic imaging (PAI) is one of the imaging modalities[43, 44] currently being 
studied to monitor HIFU therapy. PAI is a promising non-ionizing and non-invasive 
biomedical imaging technique based on the photoacoustic effect [44] with simultaneous 
sensitive optical contrast and high ultrasonic resolution. This imaging technique has been 
successfully applied for detecting early cancers[38, 44, 115] and monitoring thermal 
lesions generated by HIFU or other means[47, 48]. 
In this study, we report an enhanced-heating effect during PAI-guided HIFU 
therapy. Further study shows that this enhancement is due to the nucleation of cavitation 
during the PAI-guided HIFU process. This new finding demonstrates another advantage 
of PAI-guided HIFU. The technique will be able to facilitate the HIFU treatment process 
by enhancing heating at a relatively low HIFU intensity, and without the injection of 
micro- or nano-size particles into the blood stream. 
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Figure 5.1 System schematic.          
 
Figure 5.1 shows the schematic of the PAI-guided HIFU system. A tunable 
optical parameter oscillator (OPO) laser (Surelite OPO PLUS, Continuum, CA), pumped 
by a Q-switched Nd:YAG laser with a pulse repetition rate of 10 Hz, was employed as 
the irradiation source. The generated laser pulses were directed by a couple of prisms, 
and then formed into a ring-shaped illumination by a conical lens. A condenser lens was 
used to make the laser light confocal with a 5-MHz HIFU transducer (SU-108-013, Sonic 
Concepts, WA) (35 mm focal length), which was mounted in the middle of the condenser 
lens. A 10-MHz focused ultrasonic transducer (V315, Olympus NDT, MA) (37.5 mm 
focal length; 70% -6-dB fractional bandwidth), which acted as a photoacoustic signal 
detector, was aligned to be confocal with the HIFU transducer and laser light prior to the 
measurements. The 10-MHz PA detector can also be used as a passive cavitation detector 
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(PCD) to detect cavitation events by sensing the broadband acoustic emissions generated 
by the collapse of bubbles during HIFU ablation. Both 10-MHz and 5-MHz transducers 
were immersed in a water tank, which had a window on the bottom. The window was 
sealed with a polyethylene membrane. Samples coated with ultrasound gels were laid on 
the other side of the membrane. A 50-µm diameter, T-type thermocouple was inserted 
into the tissue sample through a needle and placed 0.5 mm away from the focal point of 
the HIFU transducer to measure the temperature rise during the HIFU ablation. In all 
experiments, beef kidney samples were used. The laser intensity on the tissue surface was 
measured to be 18 mJ/cm
2
. 
During the experiment, a function generator (HP33250A, Agilent Technologies, 
CA) was used to provide the source signals to drive the HIFU transducer. The source 
signals were first amplified by a 50-dB radio frequency amplifier (350L, ENI Technology, 
Inc., NY), and then sent to the HIFU transducer in order to induce thermal lesions in the 
sample. During PAI-guided HIFU, burst HIFU waves with 95% duty cycle were 
transmitted by the HIFU transducer with a repetition rate of 5 Hz in order to avoid signal 
interference from HIFU on PAI. Therefore, a clear PA signal could be collected by the 
10-MHz transducer at 5 Hz when the HIFU waves were off. Because the laser system 
was running at 10 Hz, 50% of the laser shots illuminated the tissue sample when HIFU 
was running. During the PAI-guided HIFU model, signals from these 50% of the laser 
shots were discarded due to the strong interference between the HIFU waves and the PA 
signals. 
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Figure 5.2 Temperature enhancement during PAI-guided HIFU. Lines with stars and 
circles represent the temperature measured by a T-type thermocouple during HIFU 
exposure when PAI system was on and off, respectively.   
 
During temperature measurement, we found that there was a temperature 
enhancement when the laser system was operating (PAI was on) during HIFU ablation.  
Figure 5.2 shows an example of the measured average temperature with standard 
deviation (STD) from five HIFU sonications through the T-type thermocouple. In these 
measurements, HIFU focal intensity level was 1000 W/cm
2
, and the sonication duration 
was 20 seconds. Although no temperature rise could be observed when the PAI system 
was operating alone, (i.e., HIFU exposure was stopped), there was clearly a temperature 
enhancement of ~15 C when the PAI system was operating during HIFU exposure. This 
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result indicates that the HIFU heating is significantly enhanced by the assistance of laser 
light. 
 
Figure 5.3 Photograph of HIFU lesions inside a tissue sample after HIFU exposure.  
 
After HIFU exposure, the tissue sample was cut open, and a photograph of the 
lesions was taken. Figure 5.3 shows a photograph of HIFU lesions inside the tissue 
sample. Each HIFU lesion was induced by a single HIFU sonication. We can clearly 
observe that the sizes of the HIFU lesions are bigger when the PAI system is on in 
comparison with that of when the PAI system is off. In addition, from one example, the 
measured lesion volumes were 3.52 mm
3
 (with the laser on) and 1.43 mm
3 
(with the laser 
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off), respectively. This result shows great enhancement in HIFU ablation due to the 
presence of laser light. The histological results further confirm that HIFU heating is 
enhanced when PAI and HIFU systems are operating concurrently. Additionally, empty 
cavities were observed in the central region of the HIFU lesions and suggested that 
cavitation might have occurred during the heating process when the laser system 
concurrently illuminated the sample. 
To further confirm the occurrence of cavitation and explain the enhanced heating 
during PAI-guided HIFU, the 10-MHz photoacoustic detector was used as a PCD [51] to 
detect broadband acoustic emission from the HIFU focal zone. During this test, HIFU 
was running continuously with different focal intensities and sonication duration of 20 s, 
and PCD signals were collected with the laser system on and off. The PCD received two 
types of signals. The first type of signals was sound scattered by the tissue sample, which 
consisted of primary 5-MHz waves from HIFU. The second type of signals was sound 
emission from cavitation, which consisted of higher harmonics of the 5-MHz waves. In 
order to separate the emissions of cavitation from the 5 MHz HIFU waves, a 10-MHz 
high-pass filter was used. With this system, an abrupt increase in higher harmonics of the 
5-MHz waves could appear in the signal spectra when cavitation occurred. For data 
collection, detected PCD time-domain signals were amplified by a pre-amplifier (5072PR, 
Olympus-NDT, MA), captured by the GageScope (CS21G8-256MSn Gage, IL), and then 
downloaded to a personal computer. At each HIFU intensity level, five HIFU lesions 
were induced on the sample by five HIFU sonications. The number of HIFU lesions with 
acoustic cavitation at different HIFU intensity levels was counted, and the results are 
shown in Table 5.1. It is shown that acoustic cavitation occurred at a lower HIFU 
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intensity (800 W/cm
2
) with the laser illumination. However, without the laser 
illumination, cavitation would not occur until the HIFU intensity reached 1700 W/cm
2
.  
Cavitation has been demonstrated to enhance HIFU heating by increasing the effective 
ultrasound absorption[116]. Therefore, the HIFU heating enhancement at a relatively low 
HIFU intensity when the PAI system was operating in this study was due to the induced 
acoustic cavitation in soft tissue.  
 
Table 5.1 Number of HIFU lesions with cavitation from five HIFU sonications at each 
HIFU intensity level with laser on and off. 
Laser on Laser off 
HIFU 
intensity 
(W/cm
2
) 
Number of lesions with 
cavitation  
HIFU intensity 
(W/cm
2
) 
Number of lesions with 
cavitation  
600 0 1500 0 
700 0 1600 0 
800 3 1700 4 
900 5 1800 5 
1000 5 1900 5 
 
While the application of HIFU therapy is expanding, the concerns related to HIFU 
treatment include prolonged treatment time for large tumors and skin burns. To reduce 
the prolonged treatment, it is necessary to enhance the heating induced by HIFU exposure. 
In general, to enhance HIFU heating, we can simply employ ultrasound waves with 
higher intensity levels. However, high-power output will induce severe skin burns and 
also present great challenges for the design of the HIFU system, including the design of 
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transducers and the electronic circuits. An alternative to very high ultrasound intensity is 
to increase the local ultrasound absorption so that more ultrasound energy can be 
deposited in the local region at a relatively low HIFU intensity level. The introduction of 
cavitation has been investigated as a mechanism to increase the local ultrasound 
absorption and enhance heating in HIFU [51, 52]. Cavitation has been shown to yield 
elevated heating rates above those produced by classical absorption in tissue [117, 118] 
and can provide a means for improving the efficacy of HIFU treatment. However, pre-
existing nucleation sites for cavitation are not omnipresent in most tissues in vivo.  Either 
ultrasound contrast agents (UCA) [66, 119, 120] or nanoparticles have been studied as 
methods of delivering nuclei into the target region[52]. The use of UCA and 
nanoparticles, however, requires the systematic injection of foreign particles into the 
blood stream, and would cause much concern regarding the toxicity, efficiency, etc.   
This letter reports a particle-free, photo-enhanced HIFU heating method with the 
utilization of a diagnostic laser system. HIFU heating was enhanced through inducing 
cavitation in soft tissue by the combination of laser light and ultrasound. In comparison 
with the other means to enhance HIFU heating, the current technique does not involve the 
use of any nanoparticles or UCA. The other advantage of the current technique is that a 
diagnostic laser system for PAI can be used. Therefore, the heating enhancement can be 
easily achieved while the treatment process is monitored by PAI.     
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Chapter 6 Laser-enhanced cavitation during high intensity focused 
ultrasound: an in vivo study 
6.1 Introduction 
High intensity focused ultrasound (HIFU) is a truly non-invasive thermal-ablation 
technique. HIFU works through rapidly depositing high intensity ultrasound energy into a 
small region to induce cell death primarily by hyperthermia after high intensity 
ultrasound is absorbed by soft tissue[8, 9, 79]. While the application of HIFU therapy is 
expanding, one concern related to HIFU treatment is the prolonged treatment time for 
large tumors because HIFU lesion is relatively small for each HIFU shot.  
Cavitation has been shown to yield elevated heating rate above those produced by 
classical acoustic absorption in tissue[51, 117, 118, 121-123] and can provide an 
effective method to improve the efficiency of HIFU treatment. However, pre-existing 
nucleation sites for cavitation are not omnipresent in most tissues in vivo.  Many research 
efforts have been made to create nucleation sites for cavitation and reduce cavitation 
threshold. Both ultrasound contrast agents (UCA)[66, 67, 119, 120, 124, 125] and 
nanoparticles have been studied as methods to deliver cavitation nuclei into the targeted 
region[52, 100]. The use of UCA or nanoparticle, however, requires the systematic 
injection of foreign particles into the blood stream, and would have a lot of concerns 
regarding the toxicity, efficiency, etc.   
Laser light has been widely used to induce cavitation through optical breakdown. 
This procedure is generally performed with high intensity light, and mostly limited to 
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clear media or sample surfaces[126, 127]. Hence the application of this technique is 
limited in the in vivo applications, where treatments in a certain depth in turbid media are 
often desired. 
In a previous study[128], we reported an enhanced heating effect during 
photoacoustic imaging-guided HIFU therapy. The results suggested that cavitation was 
enhanced when a diagnostic laser light beam illuminated the sample concurrently with 
HIFU radiation. Two features were highlighted in this previous study: 1)a diagnostic 
laser light beam was used, and the laser fluence was low and under the safety limit 
recommended by American National Standards Institute[129]; 2) cavitation was observed 
under the surface layer in a turbid medium. These results motivate us to further study the 
feasibility of laser-enhanced cavitation during HIFU, and test the limit of this technique. 
In the current study, we further investigated laser-enhanced cavitation effect 
during HIFU in an in vivo experiment. Specifically, we investigated the effect of laser on 
cavitation threshold as a function of laser wavelength, HIFU duration, and treatment 
depth. The significance of this study lies in the fact that it may develop a technique to 
facilitate cavitation during HIFU with a diagnostic laser system; hence, HIFU heating can 
be enhanced without introducing foreign particles into the targeted tissue region.  
6.2 Materials and Methods 
6.2.1 Experimental system 
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Figure 6.1 System schematic. 
 
A block diagram of experimental setup is shown in Figure 6.1. A Q-switched, 
Nd:YAG laser pumped, tunable optical parameter oscillator (OPO) laser (Surelite OPO 
PLUS, Continuum, Santa Clara, CA) with a pulse repetition rate of 10 Hz (5-ns pulse 
width), was employed as the irradiation source. The generated laser beam was formed 
into a ring-shaped illumination on a condenser lens, which was used to mount a 5-MHz 
HIFU transducer (SU-108-013, Sonic Concepts, Bothell, WA) (35 mm focal length) in 
the center hole. The condenser lens focused the laser beam underneath the HIFU 
transducer, and the optical focus overlapped with the ultrasound focus. A 10-MHz 
focused ultrasonic transducer (V315, Olympus-NDT, Waltham, MA) (37.5 mm focal 
length; 70% -6-dB fractional bandwidth), which was placed at a 90-degree angle with the 
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HIFU transducer and acted as a passive cavitation detector (PCD), was aligned to be 
confocal with the HIFU transducer and the laser beam prior to HIFU treatments. The 
signal detected by the PCD was directed to a pre-amplifier (5072PR; Olympus-NDT, 
Waltham, MA).Then, the resulting signals were captured by a data acquisition card 
(GageScope, CS21G8-256MSn Gage, Lockport, IL), and filtered by a 10-MHz high-pass 
filter to remove contributions from the HIFU fundamental and second harmonic 
frequencies in order to ensure that the detected signals were mainly received from 
broadband acoustic emissions of cavitation. Both the 10-MHz and 5-MHz transducers 
were immersed in a water tank that has a window on the bottom. The water tank was 
filled with degassed water, and the window at the bottom was sealed by a piece of 
polyethylene membrane.  
During each experiment, the source signals were generated by a function 
generator (HP33250A, Agilent Technologies, Santa Clara, CA), and amplified by a 50-
dB radio frequency amplifier (350L, ENI Technology, Inc., Rochester, NY), before they 
were sent to the HIFU transducer through a matching network to induce cavitation in the 
sample. Laser light was applied to the sample surface concurrently with HIFU 
sonications. 
6.2.2 In vivo experiment 
During the in vivo experiment, mice (BALB/c, 8-10 weeks old, female or male) 
were used. All animals have been handled and cared for in accordance with the Guide for 
the Care and Use of Laboratory Animals, and the procedures were approved by the 
Institutional Animal Care and Use Committee at the University of Kansas. Before each 
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experiment, one animal was anesthetized with a mixture of ketamine (87 mg/kg body 
weight) and xylazine (13 mg/kg body weight) and shaved in the leg region. The shaving 
procedure included the use of standard surgical hair removal lotion because hairs 
interfere with ultrasound propagation. After shaving, the animal was maintained under 
anesthesia with an isoflurane gas anesthesia machine (1-2% isoflurane in pure oxygen) 
for at least one hour to allow the animal to reach equilibrium body condition. Surgical 
tape was used to gently secure the animal onto a warmed pad. A custom-designed animal 
holder was also used to fix the animal with ear-pins and a tooth-pin. The animal was then 
secured underneath the membrane at the bottom of the water tank for the subsequent 
experiment. Ultrasound coupling gel was applied to the top surface of the sample to 
provide coupling between the membrane and the sample surface. Heart−rate and blood 
oxygenation were monitored with a pulse−oximeter during the experiment, and breathing 
was visually monitored. 
During the experiment, different combinations of laser intensities and ultrasound 
pressures were applied to the leg muscle of the animal, and the generated cavitation 
signals were detected by the PCD to determine the pressure thresholds[118] for cavitation. 
Laser wavelengths in near-infrared region such as 760 and 960 nm were used in order to 
achieve deep penetration depth. 
To obtain HIFU pressure inside the tissue sample, we first calibrated the HIFU 
transducer with a standard hydrophone, and then a simulation process was employed to 
calculate the HIFU focal pressure in the tissue sample. During the simulation process, a 
finite difference time domain (FDTD)[130] was used. The laser fluence was first 
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measured at the surface of the tissue sample. Then Beer’s law was used to estimate the 
laser fluence inside the tissue by assuming a diffusion process[131].  
In order to test the capability of generating cavitation at different depths, we used 
chicken breast tissues with different thicknesses to cover the region of interest on the 
small animal. During the experiment, the confocal point of the transducers and the laser 
was carefully aligned into a leg of the small animal at the desired depths, which were 5 
mm and 10 mm from the top sample surface in this study.  
6.3 Results 
The measured cavitation thresholds are shown in Figure 6.2. Figure 6.2(a) shows 
the measured cavitation threshold at 5 mm depth when the laser wavelength is 760 nm 
with a 2-second HIFU sonication. The result shows that the cavitation threshold 
decreases as the laser fluence increases. When no laser is applied, the detected cavitation 
threshold is 9.80 MPa. When the surface laser fluence is increased to 50 mJ/cm
2
, which 
corresponds to a fluence of 10.7 mJ/cm
2
in the HIFU focal region, the measured cavitation 
threshold is reduced to 7.89 MPa. Figure 6.2(b) shows the results with the similar 
parameter settings but the HIFU treatment depth is 10 mm. At this depth, the measured 
cavitation threshold is similar between with and without laser (10.43 MPa verses 10.31 
MPa). By using Beer’s law, we estimate that the laser fluence at the HIFU focal spot is 
only 2.3 mJ/cm
2
, which is very low and may explain the reason why laser has little effect 
on enhancing cavitation.  
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Figure 6.2 In vivo measurements of cavitation pressure threshold. The mean acoustic 
cavitation thresholds from five measurements were plotted as a function of laser fluence 
at the sample surface. Error bars are the standard deviations of five measurements.(a) 760 
nm laser wavelength, 5 mm treatment depth, 2s HIFU duration time. (b) 760 nm laser 
wavelength, 10 mm treatment depth, 2s HIFU duration time. (c) 960 nm laser wavelength, 
10 mm treatment depth, 2s HIFU duration time.(d) 760 nm laser wavelength, 10 mm 
treatment depth, 4s HIFU duration time. 
 
Figure 6.2(c) shows the results when laser wavelength 960 nm is used for 10-mm 
treatment depth. As compared with Figure 6.2(b), it shows that using laser wavelength 
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960nm reduces the cavitation threshold slightly more than using 760 nm wavelength, 
although the differences are in the range of error. The major difficulty at this depth is that 
the laser intensity drops to a very low level, and therefore, the enhancement effect on 
cavitation threshold becomes low. However, longer wavelength lights should have 
advantages to enhance cavitation in the deep region because that as the laser wavelength 
increases in near-infrared (NIR) region, light can propagate further, and therefore retain 
more energy in a certain treatment depth[132-134]. 
Figure 6.2(d) shows the measured cavitation thresholds at 10 mm depth with 760 
nm laser wavelength and a 4-second HIFU sonication. When laser light is applied, the 
cavitation cavitation threshold is reduced from 9.50 MPa to 8.76 MPa. As compared with 
Figure 6.2(b), whereas the only difference is the duration of HIFU sonication, Figure 
6.2(d) shows that laser-enhanced cavitation can be facilitated by longer HIFU sonication 
duration.  
6.4 Discussion and conclusions 
In this study, we showed in vivo results for laser-enhanced cavitation effect during 
HIFU. The results suggest that cavitation effect can be enhanced when laser light is 
applied to the sample during HIFU sonications. The magnitude of the enhancement, 
however, seems related to the applied laser fluence. The enhancement will be greater if 
the applied laser fluence is higher. Laser wavelength and HIFU duration all have effects 
on the detected cavitation threshold. The major limitation of this technique will be the 
depth because light is strongly scattered in soft tissue.  
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Laser light is well-known for its ability to nucleate cavitation through 
vaporization[127, 135]. To vaporize the surrounding fluid through either optical 
absorption or optical breakdown, high optical intensity is needed. In this study, however, 
we showed that with the combination of laser and ultrasound, cavitation was enhanced at 
a relatively low optical fluence, which complies with the laser safety limit for human 
recommended by American National Standards Institute[129]. Therefore, the cavitation 
effect showed in this study is likely due to the combination effect of laser and ultrasound, 
not laser alone.  
In summary, concurrent light illumination during HIFU has the potential to 
enhance cavitation by reducing cavitation threshold. In comparison with the other 
methods to enhance HIFU, this technique does not involve the use of any nanoparticles or 
ultrasound contrast agents.  
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Chapter 7 Laser enhanced high-intensity focused ultrasound 
thrombolysis: an in vitro study 
7.1 Introduction 
Catheter-based ultrasound has been extensively studied as an efficient method to 
treat deep venous thrombosis (DVT) clinically[53-59]. However, these methods require 
the catheter to be placed within the blood clot in order to induce mechanical disruption 
through oscillating wires at high frequency and high intensity. Although catheter-based 
ultrasound provides an invasive way for thrombolysis, it has shown that the acoustic 
energy has the ability to dissolve the clots into small debris without causing arterial 
damage, which is the basis of non-invasive ultrasonic treatment.  
High intensity focused ultrasound (HIFU) is one of the non-invasive methods to 
primarily treat abnormal tissue thermally through hyperthermia[8, 9, 79]. In HIFU 
ablation, a rapid temperature elevation due to high energy deposition rate results in the 
tissue damage. However, in pulsed-HIFU exposures with low duty cycle, which is used 
for thrombolysis, energy deposition rates are low enough that temperature rises are well 
below the threshold for thermal damage. Thus, the effect of clot disruption are obtained 
more mechanically and cavitation effect are considered to make the biggest contribution 
during the process[54, 57, 60-62]. When cavitation occurs, the growth and collapse of 
bubbles in a sound field at high frequencies produce microstreaming vortices in sufficient 
magnitude, which can dissolve thrombus[136, 137].  
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The applications of thrombolysis by HIFU treatment alone are limited and have a 
relatively low thrombolysis efficiency[63, 64], so either microbubbles or thrombolytic 
drugs are applied during focused ultrasound exposure to enhance thrombolysis. The 
addition of intravenously injected microbubbles can enhance the effects of ultrasound and 
lower the energy requirement for producing ultrasound-mediated thrombolysis through 
decreasing the cavitation threshold. This enhancement has been shown in several 
studies[57, 62, 68, 69]. Also, a few of studies[138] have shown that HIFU can improve 
thrombolysis while applying thrombolytic agent by reducing the dosage of the drug and 
lowering the risk of hemorrhagic events, but increasing its efficacy. In addition, 
microbubbles and thrombolytic drug can be combined together for targeted drug delivery, 
drug transport acceleration[70-77] and eventually enhancing thrombolysis. However, the 
use of microbubbles and thrombolytic drugs requires the systematic injection of foreign 
particles into the blood stream, and would have a lot concerns regarding the toxicity, 
efficiency, etc[78]. 
In our recent study[139], we found that when the laser system of photoacoustic 
imaging (PAI) is running simultaneously with HIFU therapy, an enhanced heating effect 
can be observed due to low cavitation threshold at a relatively low HIFU intensity. This 
finding potentially allows us to enhance HIFU heating without introducing foreign 
particles in to the targeted tissue region. Also, we expect that this discovery will be able 
to get a wider range of applications, such as thrombolysis.  
In this study, we further investigated the feasibility of laser-enhanced HIFU 
therapy in the in vitro thrombolysis application. The effects of acoustic and laser 
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parameters (pulsed HIFU wave pulse length, pressure and laser intensity) were assessed. 
More importantly, the thrombolysis efficiency were measured in both HIFU treatments 
with and without laser illumination to explore the enhancement of HIFU thrombolysis. 
7.2 Materials and Methods 
7.2.1 Experimental system 
 
Figure 7.1 System schematic. 
 
The overall experimental arrangement is shown in Figure 7.1.  The laser source 
with a pulse repetition rate of 10 Hz (5-ns pulse width) consists of a pumped Q-switched, 
Nd:YAG laser and a tunable optical parameter oscillator (OPO) laser (Surelite OPO 
PLUS, Continuum, Santa Clara, CA). The generated laser beam was formed into a ring-
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shaped illumination on a condenser lens and refocused underneath a 5-MHz HIFU 
transducer (SU-108-013, Sonic Concepts, Bothell, WA) (35 mm focal length), which was 
mounted on the condenser lens in the center hole. The focal point (-6 dB) of HIFU 
transducer is 2.61×0.51×0.51 mm. A 10-MHz focused ultrasonic transducer (V315, 
Olympus-NDT, Waltham, MA) (37.5 mm focal length; 70% -6-dB fractional bandwidth), 
which was placed at a 90-degree angle with the HIFU transducer and acted as a passive 
cavitation detector (PCD), was aligned to be confocal with the HIFU transducer and the 
laser beam prior to HIFU treatments. The HIFU source waves were generated by a 
function generator (HP33250A, Agilent Technologies, Santa Clara, CA), and amplified 
by a 50-dB radio frequency amplifier (350L, ENI Technology, Inc., Rochester, NY), 
before they were sent to the HIFU transducer through a matching network to induce 
cavitation in the sample. The PCD signal was received by a pre-amplifier (5072PR; 
Olympus-NDT, Waltham, MA) and captured by a data acquisition card (GageScope, 
CS21G8-256MSn Gage, Lockport, IL) in the personal computer. A 10-MHz high-pass 
filter was used to remove contributions from the HIFU fundamental and second harmonic 
frequencies in order to ensure that the detected signals were mainly received from 
broadband acoustic emissions of cavitation. Both the 10-MHz and 5-MHz transducers 
were immersed in a water tank filled with degassed water during the treatment.  
7.2.2 Clot preparation 
Whole bovine blood mixed with CaCl2 in ~6 mm inner diameter tygon tubing, 
was immersed in a 37ºC water bath for 2 hours and then stored at 4ºC for up to 3 days to 
generate clots. Before the experiment, the clots cut into roughly cylindrical small pieces 
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with a diameter of 5 mm and a length of 5 mm were placed in a tygon tubing (6.25 mm 
ID and 7.81 mm OD). The blood clots have a initial mass weight of 205±41 mg (n=155). 
7.2.3 Experiment procedure 
All experiments were conducted in a water container filled with degassed water. 
Each blood clot were cut and weighted before the treatment and then placed in a tygon 
tubing for exposure under HIFU transducer and laser light. During the sonication, HIFU 
transducers, PCD detector and laser beams were driven by 3-D translation stages along x, 
y and z directions. The predetermined speed of the movement along x direction was 0.25 
mm/s and the step size for y and z directions were set to 0.5 mm and 1 mm according to 
the size of the clot and HIFU transducer focal point. After the treatment, the clots were 
flushed with saline solution on a 400 µm pore size filter for weighting. The difference 
between the initial clot weight and the weight on the filter was used to calculate the 
weight loss, which is thrombolysis efficiency, and expressed by percentage. 
7.2.4 Assessment of ultrasound and laser parameters 
The experiments were performed in 3 groups. Each group contained only one 
variable (HIFU pulse length, HIFU pressure or laser fluence) with the other parameter 
remained same in order to examine the influence of each variable on thrombolysis 
efficiency. The treatment was repeated 5 times at each variable and performed both with 
and without laser illumination for comparison. The duty cycle for all treatments was 1:10. 
The laser wavelength used in this study was 760 nm. 
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7.3 Results and Discussion 
 
Figure 7.2 Thrombolysis efficiency correlated with HIFU wave pulse length in the 
treatment with and without laser radiation. 
 
The mean thrombolysis efficiency was plotted as a function of pulse length in Figure 7.2. 
The HIFU pressure and laser fluence used in this group was 13.2 MPa and 27 mJ/cm
2
, 
respectively. This laser fluence at 760 nm laser wavelength was slightly higher than the 
safety limit recommended by American National Standards Institute[129], which is 26.4 
mJ/cm
2
. As we can see in the figure, longer pulse length yielded higher thrombolysis 
efficiency until it tended to reach a saturation stage. With laser, the saturation point (800 
µs pulse length) was reached earlier than it in the treatment without laser (1000 µs). In 
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the rise stage of the curves, the thrombolysis efficiency was greatly enhanced by laser. At 
the pulse length of 800 µs, the enhancement was about 53.1%. To further investigate the 
possible reason of this enhancement, acoustic cavitation signals were detected at each 
pulse length by the transducer. It is shown that cavitation threshold in the treatments with 
laser was at 400 µs pulse length. However, without the laser illumination, the cavitation 
will not occur until the pulse length reached 1000 µs. As we know, cavitation has been 
demonstrated to enhance thrombolysis effect. Therefore, the enhancement of HIFU 
thrombolysis treatment was due to the laser-induced acoustic cavitation. 
 
Figure 7.3 Thrombolysis efficiency measured under different HIFU pressures with and 
without laser radiation. 
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To test the influence of HIFU pressure on thrombolysis efficiency, HIFU pulse 
length (1000 µs) and laser fluence (27 mJ/cm
2
) were fixed. It is indicated in Figure 7.3 
that at 5 and 7 MPa HIFU pressure, the thrombolysis efficiency were only about 21.1±3.0% 
and 18.6±3.9%. However, as the HIFU pressure increases, a maximum of 74.2±2.8% clot 
weight loss can be reached. Also, treatment with ultrasound alone produced less 
thrombolysis than it with the presence of laser. In addition, acoustic cavitation can be 
observed at 7 and 9 MPa with and without laser help. Thus, similarly, it is demonstrated 
again that the laser illumination has successfully lowered cavitation threshold and 
therefore enhanced the HIFU thrombolysis efficiency. 
    
Figure 7.4 Thrombolysis efficiency with increasing laser fluence. 
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The increasing laser effect on thrombolysis effect was also examined as shown in 
Figure 7.4. The HIFU pressure was determined to be 9.18 MPa and HIFU wave pulse 
length was 1000 µs in these treatments. Acoustic cavitation threshold was observed at 
laser fluence of 16 mJ/cm
2
. At laser fluence smaller than 16 mJ/cm
2
, there was low 
thrombolysis efficiency. However, as the laser fluence increased, a steep increase in 
thrombolysis efficiency can be seen in the plot, which attributes the success to the laser 
induced cavitation. 
7.4 Conclusion  
This study investigated the feasibility of using laser induced cavitation to enhance 
in vitro HIFU thrombolysis treatment without any addition of thrombolytic agent or 
microbubbles. Three important ultrasound and laser parameters (HIFU wave pulse length, 
HIFU pressure, laser fluence) were chosen to test their influence on thrombolysis 
efficiency. In most case, the larger the pulse length, HIFU pressure and laser fluence, the 
better the thrombolysis efficiency can be obtained. The optimal parameters were a pulse 
length of 1000 µs, HIFU pressure of 13 MPa and under 27 mJ/cm
2
 laser radiation, at 
which a maximum thrombolysis efficiency (74.2±2.8%)were achieved. This in vitro data 
will help to establish an optimal strategy for laser enhanced HIFU thrombolysis. 
In addition, significant enhancement of thrombolysis efficiency was observed 
with laser illumination. Laser induced cavitation was considered to be a primary factor in 
the enhancement of HIFU thrombolysis treatment, because it is shown that cavitation 
threshold was  greatly reduced when laser was running concurrently with HIFU treatment. 
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We have shown in our previous study[139] that laser enhanced HIFU treatment 
can be used in soft tissue thermal ablation. In this study, the results implied that this 
technique without any external agent added has successfully shown another potential 
application in the thrombolysis field. More future work is need to evaluate its in vivo and 
clinical feasibility and potential risk of injury of vessel wall and surrounding tissue. 
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Chapter 8 Conclusion 
8.1 Summary 
The goal of this dissertation is to understand that photoacoustic imaging can be 
performed to increase the accuracy and efficacy of HIFU treatment. Four main sections 
were presented in this study. First, our results included the investigation of feasibility of 
integrated PAI and HIFU system to guide HIFU thermal necrosis both ex vivo and in 
vivo. Second, the real time PAI monitoring HIFU was applied for accurate evaluation of 
thermal ablation outcomes. Third, during PAI monitoring HIFU, a significant 
enhancement of both temperature elevation and lesion size were found, therefore, laser 
enhanced HIFU treatment were presented with cavitation detection. Finally, we expanded 
this laser enhanced technique to thrombolysis application. The results obtained from 
above four applications form the primary contribution of this dissertation, which is to 
demonstrate photoacoustic imaging, other than ultrasound imaging and MRI, can not 
only be used to guide, monitor HIFU treatment, but also improve HIFU treatment by 
enhancing cavitation effect. 
8.2 Findings 
According to the obtained results for the four sections, we concluded a set of 
findings.  
In the first section, an integrated PAI and HIFU system was developed and used 
to treat soft tissue. Based on the successful experience with ex vivo experiment, the in 
vivo HIFU ablation on tumors was performed. In the in vivo experiment, gold nanorods 
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was employed as a contrast agent to enhance the target imaging contrast. Two weeks 
after the treatment, the tumor on the leg area of the BALB/c mouse cannot be observed 
and the lesion was healed. The outcome of both ex vivo and in vivo PAI guided HIFU 
ablation is to prove that it is feasible for PAI to be a guidance and evaluation tool for 
HIFU therapy. 
Generally, the transducers used in treatment operate in the 1-10 MHz frequency 
range, with 2-4 MHz being the most common. However, a HIFU transducer with 5 MHz 
central frequency was used throughout this work. The reason of choosing 5 MHz is that 
the HIFU transducer in this study was not only acted as an ultrasound transmitter, but 
also a photoacoustic signal receiver. Thus, choosing 5 MHz central frequency can allow 
us to find a balance between transducer sensitivity (energy delivery) and imaging quality 
(axial resolution).  
The second section is to find out a better way to monitor HIFU ablation in soft 
tissue in real time. Currently, all studies were using temperature change to estimate the 
tissue necrosis, and the temperature was measured indirectly by using the change of 
sound speed. However, the drawback is that the sound speed measurement may not be 
accurate since the tissue property changes during the heating. Thus, the temperature 
measurement is not a reliable methods for tissue coagulation. In our experiment, a 10 
MHz ultrasonic transducer was added to the system for receiving photoacoustic signals 
between two HIFU burst cycles to eliminate the interference of strong HIFU signals. The 
results showed that PA amplitude increased during HIFU and finally reached a saturation 
stage, which was an indication of complete tissue coagulation. The third finding is that 
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the change in PA amplitude during HIFU is about 3-fold (Fig.9). Therefore, the 
sensitivity of PA detection using 5-MHz HIFU transducer seems very high. 
In the third section, we found that HIFU heating is enhanced when PAI technique 
is used to monitor HIFU lesion formation. We tested this technique both in ex vivo soft 
tissue and in vivo mice tissue. The 10 MHz transducer was not used as a photoacoustic 
signal detector but a passive cavitation detector. It is observed in the ex vivo experiment 
that a 15ºC temperature difference  and a larger lesion volume when laser was running 
concurrently with HIFU heating. In the in vivo measurement, the cavitation pressure 
threshold was significantly lowered when laser presented. It seems that the laser 
illumination is the key for the heating enhancement. The possible reason for the 
enhancement is due to the decrease of cavitation threshold at a relatively lower HIFU 
pressure. 
Finally, in the fourth section, we tested the laser enhance HIFU therapy in the 
pulsed HIFU thrombolysis application. There are two outcomes from this section. First, 
the result helped us establish an optimal strategy for laser enhanced HIFU thrombolysis. 
Second, the results showed great improvement of thrombolysis efficiency (blood clot 
weight loss) and laser induced cavitation was considered to be a primary factor, because 
the cavitation pressure threshold was reduced by laser radiation. 
8.3 Suggestions for future work 
More efforts are still needed to improve the treatment planning and optimize the 
parameters to improve predictability for laser enhanced HIFU therapy. 
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1. The typical lateral size of the HIFU beam focal area is smaller than 1 mm, and 
usually much smaller than the tumor size. Also, the tumor may distorted unpredictably in 
their shape during the heating because the change of tissue properties. Thus, a higher 
imaging quality is needed to accurately profile the tumor for ablation. Moreover, a 
scheme is necessary in order to enhance the efficacy of HIFU therapy. 
2. More experimental results should be obtained and analyzed in order to find out 
the lesion volumes under different combinations of ultrasound, laser and tissue 
parameters. This will help us to treat a certain size of tumor more accurately and thus 
more efficiently. 
2. Since HIFU treatment is a very complex process and related to a lot of factors, 
a theoretical modeling of acoustic and temperature field with amplitude, frequency, and 
geometry of the HIFU transducer, tissue properties and heat diffusion is need to optimize 
the parameters of HIFU transducer and treatment protocol. 
3. The treatment depth of laser enhanced HIFU therapy is not deep enough for 
wider applications. Either better laser system or proper treatment strategy should be 
employed to increase the laser fluence in the targeted area several centimeter inside the 
soft tissue. 
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